Disseminated Intravascular Coagulation (DIC) Market
完整報告名稱與涵蓋範圍
Disseminated Intravascular Coagulation (DIC) Market Size, Share & Trends Analysis Report By Symptoms (Bleeding, Blood Clots, Bruising, Drop in Blood Pressure, Shortness of Breath, Confusion, Fever), Treatment (Medicines, Transfusions, Surgery), Diagnosis (Complete Blood Count with Blood Smear Exam, Partial Thromboplastin Time (PTT), Prothrombin Time (PT), Fibrinogen Blood Test, D-dimer), Route of Administration, End-Users, Distribution Channel, By Region, And By Segment Forecasts, 2024-2031.
報告摘要
The Disseminated Intravascular Coagulation (DIC) Market on a global scale was estimated at USD 437.3 Mn in 2023 and is poised to attain USD 563.8 Mn by 2031, with a projected CAGR of 3.3% between 2024 and 2031.
Disseminated Intravascular Coagulation (DIC) covers The Disseminated Intravascular Coagulation (DIC) market focuses on managing a serious condition characterized by abnormal blood clotting, involving key segments such as diagnostics (e.g., D-dimer test. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is bolstered by growing healthcare spending, technological evolution, and the growing focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and growing investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Disseminated intravascular coagulation (DIC) Market Snapshot
Chapter 4. Global Disseminated intravascular coagulation (DIC) Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Symptoms Estimates & Trend Analysis
5.1. by Symptoms & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Symptoms:
5.2.1. Bleeding
5.2.2. Blood Clots
5.2.3. Bruising
5.2.4. Drop in Blood Pressure
5.2.5. Shortness of Breath
5.2.6. Confusion
Chapter 6. Market Segmentation 2: by Distribution Channel Estimates & Trend Analysis
6.1. by Distribution Channel & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Distribution Channel:
6.2.1. Hospital Pharmacy
6.2.2. Retail Pharmacy
6.2.3. Online Pharmacy
6.2.4. Others
Chapter 7. Market Segmentation 3: by Diagnosis Estimates & Trend Analysis
7.1. by Diagnosis & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Diagnosis:
7.2.1. Complete Blood Count with Blood Smear Exam
7.2.2. Partial Thromboplastin Time (PTT)
7.2.3. Prothrombin Time (PT)
7.2.4. Fibrinogen Blood Test
7.2.5. D-dimer
7.2.6. Others
Chapter 8. Market Segmentation 4: by End-User Estimates & Trend Analysis
8.1. by End-User & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-User:
8.2.1. Hospitals
8.2.2. Specialty Clinics
8.2.3. Homecare
8.2.4. Others
Chapter 9. Market Segmentation 5: by Treatment Estimates & Trend Analysis
9.1. by Treatment & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Treatment:
9.2.1. Medicines
9.2.2. Transfusions
9.2.3. Surgery
9.2.4. Others
Chapter 10. Market Segmentation 6: by Route of Administration Estimates & Trend Analysis
10.1. by Route of Administration & Market Share, 2019 & 2031
10.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Route of Administration:
10.2.1. Oral
10.2.2. Parenteral
10.2.3. Others
Chapter 11. Disseminated intravascular coagulation (DIC) Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Symptoms, 2023-2031
11.1.2. North America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
11.1.3. North America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2023-2031
11.1.4. North America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
11.1.5. North America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
11.1.6. North America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
11.1.7. North America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.2. Europe
11.2.1. Europe Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Symptoms, 2023-2031
11.2.2. Europe Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
11.2.3. Europe Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2023-2031
11.2.4. Europe Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
11.2.5. Europe Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
11.2.6. Europe Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
11.2.7. Europe Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.3. Asia Pacific
11.3.1. Asia Pacific Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Symptoms, 2023-2031
11.3.2. Asia Pacific Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
11.3.3. Asia-Pacific Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2023-2031
11.3.4. Asia-Pacific Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
11.3.5. Asia-Pacific Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
11.3.6. Asia-Pacific Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
11.3.7. Asia Pacific Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.4. Latin America
11.4.1. Latin America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Symptoms, 2023-2031
11.4.2. Latin America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
11.4.3. Latin America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2023-2031
11.4.4. Latin America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
11.4.5. Latin America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
11.4.6. Latin America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
11.4.7. Latin America Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
11.5. Middle East & Africa
11.5.1. Middle East & Africa Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Symptoms, 2023-2031
11.5.2. Middle East & Africa Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2023-2031
11.5.3. Middle East & Africa Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2023-2031
11.5.4. Middle East & Africa Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2023-2031
11.5.5. Middle East & Africa Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2023-2031
11.5.6. Middle East & Africa Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2023-2031
11.5.7. Middle East & Africa Disseminated intravascular coagulation (DIC) Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Moderna, Inc.
12.2.2. Alnylam Pharmaceuticals, Inc.
12.2.3. Sanofi
12.2.4. Olix Pharmaceuticals, Inc.
12.2.5. Glaxosmithkline Plc.
12.2.6. Benitec Biopharma
12.2.7. Arbutus Biopharma Corporation
12.2.8. Silence Therapeutics
12.2.9. Rexahn Pharmaceuticals, Inc.
12.2.10. Arrowhead Pharmaceuticals, Inc.
12.2.11. Quark
12.2.12. Dicerna Pharmaceuticals (Novo Nordisk A/S)
12.2.13. Thermo Fisher Scientific Inc
12.2.14. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們